Keywords: گیرنده آنتی ژنهای کرومیک; Cancer stem cell; Mesenchymal stem cell; Immunosuppression; Chimeric antigen receptor; Drug delivery; Dormancy;
مقالات ISI گیرنده آنتی ژنهای کرومیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گیرنده آنتی ژنهای کرومیک; Osteonecrosis of the jaw; Medication-related osteonecrosis of the jaw; Bisphosphonate-related osteonecrosis of the jaw; Antiresorptive therapy; Preventive measures; Plasma-rich in growth factors; Extraction; Cancer patients; MRONJ; medication-related oste
Keywords: گیرنده آنتی ژنهای کرومیک; Biotherapeutics; Gene and cell therapy; Pharmacokinetics; Non-clinical safety; Immunogenicity; Cross-reactive species; ATMP; advanced therapy medicinal products; CAR; chimeric antigen receptor; CD; cluster of differentiation; CMC; chemistry manufacturing
Keywords: گیرنده آنتی ژنهای کرومیک; T1DM; Type 1 diabetes mellitus; EDS; Search E-Resources; IGF1; insulin-like growth factor 1; NOD; non-obese diabetic; G6Pase; glucose-6-phosphatase; HGF; hepatocyte growth factor; SCID; severe combined immunodeficiency; BTC; betacellulin; Ngn3; Neurogenin
Keywords: گیرنده آنتی ژنهای کرومیک; Adoptive cell transfer; Chimeric antigen receptor; Graft versus host disease; Hematopoietic stem cell transplant; Metabolism; Tumor infiltrating lymphocyte;
Keywords: گیرنده آنتی ژنهای کرومیک; Cellular therapy; Checkpoint; Chimeric antigen receptor; Microenvironment; PD-1 inhibitors;
Keywords: گیرنده آنتی ژنهای کرومیک; ARID; Age Related Immune Dysfunction; BCG; Bacille Calmette-Guérin; CAR; chimeric antigen receptor; CDMRP; Congressionally Directed Medical Research Program; CD40L; CD40 ligand; CpG; poly-(cysteine 5â² to guanine); CRISPR; clustered regularly interspace
Keywords: گیرنده آنتی ژنهای کرومیک; Acute lymphoblastic leukemia; ALL; Blinatumomab; CAR; Chimeric antigen receptor; CRS; Cytokine release syndrome; IL-6; Tocilizumab;
Keywords: گیرنده آنتی ژنهای کرومیک; Synthetic biology; Cell-based device; Synthetic receptor; Immunotherapy; Robustness; Intercellular variation; CAR; Chimeric antigen receptor; GLP-1; Glucagon-like peptide-1; HEK; Human embryonic kidney; IL; Interleukin; iPSC; Induced pluripotent stem cell
Keywords: گیرنده آنتی ژنهای کرومیک; bsAb; bispecific antibody; CAR; chimeric antigen receptor; CDN; cyclic dinucleotides; CTL; cytotoxic T lymphocyte; CTLA-4; cytotoxic T-lymphocyte-associated protein 4; GM-CSF; granulocyte-monocyte colony stimulating factor; IR; irradiation; PD-1; Programm
Keywords: گیرنده آنتی ژنهای کرومیک; APC; antigen-presenting cells; BBB; blood brain barrier; CAR; chimeric antigen receptor; CSF-1R; colony stimulating factor-1 receptor; CTLA-4; cytotoxic T lymphocyte antigen 4; dcLN; deep cervical lymph node; DC; dendritic cells; FoxP3; forkhead box P3; G
Keywords: گیرنده آنتی ژنهای کرومیک; Chimeric antigen receptor; Bispecific antibody; Hepatocellular carcinoma; Treatment;
Keywords: گیرنده آنتی ژنهای کرومیک; bNAbs; broadly neutralizing antibodies; CAR; chimeric antigen receptor; CTL; cytotoxic T lymphocyte; HSC; hematopoietic stem cell; TCR; T cell receptor;
Keywords: گیرنده آنتی ژنهای کرومیک; CAR; chimeric antigen receptor; Treg; regulatory T cell; PD-1; programmed death-1; CTLA-4; cytotoxic T-lymphocyte-associated protein 4; PD-L1; programmed death ligand 1; APC; antigen-presenting cell; DC; dendritic cell; TLR; toll-like receptor; OVA; ovalb
Keywords: گیرنده آنتی ژنهای کرومیک; BCG vaccine; cancer vaccines; cell cycle checkpoints; immunotherapy; urologic neoplasms; AE; adverse event; APC; antigen presenting cell; BCG; bacillus Calmette-Guérin; CAR; chimeric antigen receptor; CIS; carcinoma in situ; CTA; cancer testis antigen; C
Keywords: گیرنده آنتی ژنهای کرومیک; BBB; blood brain barrier; CAR; chimeric antigen receptor; CNS; central nervous system; CRS; cytokine release syndrome; EGFR; epidermal growth factor receptor; EGFRvIII; variant 3 of epidermal growth factor receptor; epha2; erythropoietin producing hepatoc
Keywords: گیرنده آنتی ژنهای کرومیک; Adoptive cellular therapy; Chimeric antigen receptor; Immunosuppression; Cancer; Immunotherapy;
Keywords: گیرنده آنتی ژنهای کرومیک; 2D-LC; two-dimensional liquid chromatography; AA; amino acid; AC; affinity chromatography; ADC; antibody-drug conjugates; ADCC; antibody-dependent cellular cytotoxicity; AF4; asymmetric flow field fractionation; APTS; 1-aminopyrene-3,6,8-trisulfonate; Asn
Keywords: گیرنده آنتی ژنهای کرومیک; Acute lymphoblastic leukemia; ALL; Antibody; Blinatumomab; BiTE; CAR; Chimeric antigen receptor; Inotuzumab
Keywords: گیرنده آنتی ژنهای کرومیک; Adoptive cellular therapy; Pediatrics; Stem cell transplantation; Chimeric antigen receptor
Keywords: گیرنده آنتی ژنهای کرومیک; HNSCC; Immunotherapy; CTLA-4; PD-1; Cetuximab; Vaccine; Chimeric antigen receptor;
Keywords: گیرنده آنتی ژنهای کرومیک; advanced therapy medicinal product; advanced therapy medicinal product with hospital exemption; genetically modified organism; market access; ADI; aid for development of innovation; AFM; French Association against Myopathies (Association Française contre
T-cell receptor gene therapy - ready to go viral?
Keywords: گیرنده آنتی ژنهای کرومیک; T-cell receptor; Gene therapy; Cancer; Immunotherapy; T cell; ACT; adoptive cell therapy; allo-SCT; allogeneic stem cell transplantation; APC; antigen-presenting cell; BLAST; basic local alignment search tool; CAR; chimeric antigen receptor; CTL; cytotoxi
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
Keywords: گیرنده آنتی ژنهای کرومیک; Immune Response Heterogeneity; Immune Therapy; Antitumor Immunity; Pancreatic Cancer Treatment; CAR; chimeric antigen receptor; CARTmeso; mesothelin-specific CAR T cells; FDG; 18F-2-fluoro-2-deoxy-D-glucose; IL; interleukin; MAV; metabolically active volu
CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy
Keywords: گیرنده آنتی ژنهای کرومیک; CRISPR/CAS9; Cancer immunotherapy; Chimeric antigen receptor; TCR; Adoptive immunotherapy;
Short-term culture with IL-2 is beneficial for potent memory chimeric antigen receptor T cell production
Keywords: گیرنده آنتی ژنهای کرومیک; IL-2; Chimeric antigen receptor; Memory T cell;
Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells
Keywords: گیرنده آنتی ژنهای کرومیک; Glioblastoma; Convection Enhanced Delivery; CED; Immunotherapy; Chimeric antigen receptor; CARs;
Potential advantages of CD1-restricted T cell immunotherapy in cancer
Keywords: گیرنده آنتی ژنهای کرومیک; ACT; adoptive cell therapy; MHC; major histocompatibility complex; TCR; T cell receptor; TIL; tumor-infiltrating lymphocyte; TAA; tumor-associated antigen; APC; antigen-presenting cell; DC; dendritic cell; HSCT; hematopoietic stem cell transplantation; Gv
Wnt pathway activator TWS119 enhances the proliferation and cytolytic activity of human γδT cells against colon cancer
Keywords: گیرنده آنتی ژنهای کرومیک; ACT; Adoptive cell therapy; APCs; Antigen presenting cells; CAR; Chimeric antigen receptor; CCR5; CC-chemokine receptor 5; CFSE; Carboxyfluorescein succinimidyl ester; CRC; Colorectal cancer; GSK-3β; Glycogen synthase kinase-3β; IFN-γ; Interferon-γ; L
Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safety
Keywords: گیرنده آنتی ژنهای کرومیک; Adoptive cell therapy; Chimeric antigen receptor; Engineering; Cancer immunotherapy;
CARs and other T cell therapies for MM: The clinical experience
Keywords: گیرنده آنتی ژنهای کرومیک; Multiple myeloma; Immunotherapy; T-lymphocytes; Chimeric antigen receptor; B-cell maturation antigen; BCMA; Adoptive transfer;
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy
Keywords: گیرنده آنتی ژنهای کرومیک; acute myeloid leukemia; CAR T; chimeric antigen receptor; gamma retrovirus; Good manufacturing practice cell therapy; multiple myeloma; NKG2D;
Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity
Keywords: گیرنده آنتی ژنهای کرومیک; adoptive cellular therapy; C-type lectin; carbohydrate recognition domain; CD4; chimeric antigen receptor; functional cure; human immunodeficiency virus; mannose binding lectin;
Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology
Keywords: گیرنده آنتی ژنهای کرومیک; Regulatory T cells; Chimeric antigen receptor; Immunotherapy; CD28; CD137 (4-1BB);
Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells
Keywords: گیرنده آنتی ژنهای کرومیک; antibody-dependent cell-mediated cytotoxicity; artificial antigen-presenting cells; chimeric antigen receptor; gamma delta T cells;
Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center
Keywords: گیرنده آنتی ژنهای کرومیک; CAR T cells; Cellular therapy; Chimeric antigen receptor; Cytokine release syndrome; Diffuse large B cell lymphoma; Acute lymphoblastic leukemia;
Engineered CAR T cells targeting mesothelin by piggyBac transposon system for the treatment of pancreatic cancer
Keywords: گیرنده آنتی ژنهای کرومیک; Chimeric antigen receptor; piggyBac transposon; Mesothelin; Pancreatic cancer;
La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease
Keywords: گیرنده آنتی ژنهای کرومیک; Autoantibodies; La/SSB; Chimeric autoantibody receptor; Autoimmune diseases; NK92MI cells; LaA; 1-107 amino acid of La/SSB; BCR; B cell receptor; LaA-BCR; LaA specific B cell receptor; CAAR; Chimeric autoantibody receptor; NK92MI; NK-92 cell line by trans
Effects of cryopreservation on chimeric antigen receptor T cell functions
Keywords: گیرنده آنتی ژنهای کرومیک; Chimeric antigen receptor; B cell maturation antigen; Cryopreservation; Immunotherapy;
CAR-T cells and combination therapies: What's next in the immunotherapy revolution?
Keywords: گیرنده آنتی ژنهای کرومیک; CAR; chimeric antigen receptor; iRs; inhibitory receptors; mAbs; monoclonal antibodies; SMIs; Small molecule inhibitors; KIs; kinase inhibitors; CAR-T cells; Solid tumors; Targeted-therapies; Combination therapies; Synthetic biology; Systems biology;
The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy
Keywords: گیرنده آنتی ژنهای کرومیک; αβ; alpha beta; ADCC; antibody-dependent cellular cytotoxicity; APC; antigen-presenting cell; BrHPP; bromohydrin pyrophosphate; BTLA; B and T lymphocyte attenuator; CAR; chimeric antigen receptor; DC; dendritic cell; γc; common gamma; γδ; gamma delta
Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3
Keywords: گیرنده آنتی ژنهای کرومیک; Antiviral; Immune Response; Immune Therapy; LTB; 3-D; 3-dimensional; AE-T; activated T; APOBEC3; apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3; CAR; chimeric antigen receptor; cccDNA; covalently closed circular DNA; E:T; effector cell-to
Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell
Keywords: گیرنده آنتی ژنهای کرومیک; NK cell; natural killer cell; IFN-γ; interferon-γ; IL; interleukin; TNF-α; tumor necrosis factor-α; CCL; C-C motif ligand; GM-CSF; granulocyte-macrophage colony-stimulating factor; ADCC; antibody dependent cell-mediated cytotoxicity; TRAIL; TNF-relate
Is Disease-Specific Immunotherapy a Potential Reality for MDS?
Keywords: گیرنده آنتی ژنهای کرومیک; Adoptive T cell therapy; BiTE; Chimeric antigen receptor; Immune checkpoints; Tumor antigens;
Antigen-specific regulatory T cells: are police CARs the answer?
Keywords: گیرنده آنتی ژنهای کرومیک; CEA; carcinoembryonic antigen; CAR; chimeric antigen receptor; EAE; experimental autoimmune encephalomyelitis; HLA; human leukocyte antigen; HSCT; Hematopoietic stem cell transplantation; LAP; latency-associated peptide; PBMC; peripheral blood mononuclear
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells
Keywords: گیرنده آنتی ژنهای کرومیک; ACT; Adoptive cell transfer; ADCC; Antibody-Dependent Cell-mediated Cytotoxicity; CAR; Chimeric antigen receptor; CIK; Cytokine Induced Killer cells; CMV; Cytomegalovirus; EGFR; Human epidermal growth factor 1; GVHD; Graft-versus-Host disease; ICI; Immune
Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors
Keywords: گیرنده آنتی ژنهای کرومیک; CAR-T cells; Checkpoint inhibitors; Chimeric antigen receptor; Immune-oncology; Multiple myeloma;
Original ArticleIntracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells
Keywords: گیرنده آنتی ژنهای کرومیک; Lung cancer; Mesothelioma; Chimeric antigen receptor; Epidermal growth factor receptor; BLI; bioluminescence imaging; CAR; chimeric antigen receptor; EGFR; epidermal growth factor receptor; ffLuc; firefly luciferase; IL; interleukin; i.p.; intraperitoneal
T-cell target antigens across major gynecologic cancers
Keywords: گیرنده آنتی ژنهای کرومیک; Cancer antigen; Immunotherapy; Chimeric antigen receptor; T-cell receptor; Ovarian cancer; Cervical cancer; Endometrial cancer;
CAR T-cell therapy for lung cancer and malignant pleural mesothelioma
Keywords: گیرنده آنتی ژنهای کرومیک; ACT; adoptive cell therapy; ADC; adenocarcinoma; ALK; anaplastic lymphoma kinase; CAF; cancer-associated fibroblast; CAR; chimeric antigen receptor; CEA; carcinoembryonic antigen; CTLA-4; cytotoxic T-lymphocyte associated protein 4; DNR; dominant negative